Antitumor and antimetastatic effect of warfarin and heparins
Authors:
- Vladimir BobekVBVladimir Bobek
- Josef KovaříkJKJosef Kovařík
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 58 (4) , 213-219
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic propertiesGlycobiology, 1996
- Role of Extracellular Matrix on Colonic Cancer Cell Migration and ProliferationBiochemical and Biophysical Research Communications, 1996
- Efficacy of Low-Molecular-Weight Heparin and Unf ractionated Heparin to Prevent Adhesion of Human Prostate and Bladder Carcinoma and Melanoma Cells to Bovine Endothelial MonolayersUrologia Internationalis, 1996
- Variations in the Size and Sulfation of Heparin Modulate the Effect of Heparin on the Binding of VEGF165 to Its ReceptorsBiochemical and Biophysical Research Communications, 1994
- Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysisBlood Coagulation & Fibrinolysis, 1993
- The role of fibrin in tumor metastasisCancer and Metastasis Reviews, 1992
- Inhibition of growth and angiogenesis of human neurofibrosarcoma by heparin and hydrocortisoneJournal of Neurosurgery, 1990
- RGD-independent cell adhesion to the carboxy-terminal heparin-binding fragment of fibronectin involves heparin-dependent and -independent activities.Journal of Cell Biology, 1990
- Comparison of metastatic cell lines derived from a murine mammary tumour, and reduction of metastasis by heparinClinical & Experimental Metastasis, 1988
- Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of CortisoneScience, 1983